CGEM vs CUBE
Cullinan Oncology LLC (CGEM) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
CGEM currently screens at market cap $830.3M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the CGEM and CUBE stock pages for the full models.
Not investment advice.